Form FWP Morgan Stanley Finance Filed by: Morgan Stanley Finance LLC

September 29, 2022 6:07 AM EDT

Get inside Wall Street with StreetInsider Premium. Claim your 1-week free trial here.

Free Writing Prospectus to Preliminary Terms No. 6,467

Registration Statement Nos. 333-250103; 333-250103-01

Dated September 30, 2022; Filed pursuant to Rule 433

Morgan Stanley

6-Year SPX Dual Directional Buffered PLUS

This document provides a summary of the terms of the Buffered PLUS. Investors must carefully review the accompanying preliminary terms referenced below, product supplement, index supplement and prospectus, and the “Risk Considerations” on the following page, prior to making an investment decision


Issuing entity:

Morgan Stanley Finance LLC


Morgan Stanley


S&P 500® Index (SPX)

Leverage factor:

105% to 120%

Buffer amount:

25% of principal (75% maximum loss)1

Pricing date:

October 26, 2022

Valuation date:

October 26, 2028

Maturity date:

October 31, 2028



Preliminary Terms:

1All payments are subject to our credit risk



Hypothetical Payout at Maturity1


Change in Underlying

Return on Buffered PLUS







































*Assumes a leverage factor of 105%

The issuer has filed a registration statement (including a prospectus) with the SEC for the offering to which this communication relates. Before you invest, you should read the prospectus in that registration statement and other documents the issuer has filed with the SEC for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC Web site at Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-800-584-6837.

Underlying Index

For more information about the underlying index, including historical performance information, see the accompanying preliminary terms.

Risk Considerations

The risks set forth below are discussed in more detail in the “Risk Factors” section in the accompanying preliminary terms. Please review those risk factors carefully prior to making an investment decision.

Risks Relating to an Investment in the Buffered PLUS

The Buffered PLUS do not pay interest and provide a minimum payment at maturity of only 25% of your principal.

The market price of the Buffered PLUS will be influenced by many unpredictable factors.

The Buffered PLUS are subject to our credit risk, and any actual or anticipated changes to our credit ratings or credit spreads may adversely affect the market value of the Buffered PLUS.

As a finance subsidiary, MSFL has no independent operations and will have no independent assets.

The estimated value of the Buffered PLUS is $926.10 per Buffered PLUS, or within $55.00 of that estimate, and is determined by reference to our pricing and valuation models, which may differ from those of other dealers and is not a maximum or minimum secondary market price.

The amount payable on the Buffered PLUS is not linked to the value of the underlying index at any time other than the valuation date.

Investing in the Buffered PLUS is not equivalent to investing in the underlying index.

The rate we are willing to pay for securities of this type, maturity and issuance size is likely to be lower than the rate implied by our secondary market credit spreads and advantageous to us. Both the lower rate and the inclusion of costs associated with issuing, selling, structuring and hedging the Buffered PLUS in the original issue price reduce the economic terms of the Buffered PLUS, cause the estimated value of the Buffered PLUS to be less than the original issue price and will adversely affect secondary market prices.

The Buffered PLUS will not be listed on any securities exchange and secondary trading may be limited.

The calculation agent, which is a subsidiary of Morgan Stanley and an affiliate of MSFL, will make determinations with respect to the Buffered PLUS.

Hedging and trading activity by our affiliates could potentially adversely affect the value of the Buffered PLUS.

The U.S. federal income tax consequences of an investment in the Buffered PLUS are uncertain.

Risks Relating to the Underlying Index

Adjustments to the underlying index could adversely affect the value of the Buffered PLUS.

Tax Considerations

You should review carefully the discussion in the accompanying preliminary terms under the caption “Additional Information About the Buffered PLUS– Tax considerations” concerning the U.S. federal income tax consequences of an investment in the Buffered PLUS, and you should consult your tax adviser.


Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

SEC Filings

Related Entities

Morgan Stanley